Financhill
Back

Incyte Quote, Financials, Valuation and Earnings

Sell
50

INCY
Incyte

Last Price:
57.07
Seasonality Move:
0.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Incyte Price Quote

$57.07
-0.03 (0.37%)
(Updated: May 18, 2024 at 5:46 AM ET)

Incyte Key Stats

Sell
50
Incyte (INCY) is a Sell

Day range:
$56.40 - $57.25
52-week range:
$50.27 - $67.37
Dividend yield:
0%
P/E ratio:
21.55
P/S ratio:
3.43
P/B ratio:
2.38%

Volume:
1.6M
Avg. volume:
2.2M
1-year change:
-11.54%
Market cap:
$12.8B
Revenue:
$3.7B
EPS:
$3.3

How Much Does Incyte Make?

  • How Much Are Incyte's Sales Annually?
    INCY Revenues are $3.7B
  • How Much Profit Does Incyte's Make A Year?
    INCY net income is $597.6M

Is Incyte Growing As A Company?

  • What Is Incyte's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Incyte's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 6.5%

Incyte Stock Price Performance

  • Did Incyte Stock Go Up Last Month?
    Incyte share price went up by 8.31% last month
  • Did INCY's Share Price Rise Over The Last Year?
    INCY share price fell by -11.54% over the past 1 year

What Is Incyte 52-Week High & Low?

  • What Is Incyte’s 52-Week High Share Price?
    Incyte has traded as high as $67.37 over the past 52 weeks
  • What Is Incyte’s 52-Week Low Share Price?
    Incyte has traded as low as $50.27 over the past 52 weeks

Incyte Price To Free Cash Flow

  • Is Incyte Stock Overvalued?
    Incyte is trading at a price to free cash flow ratio of 16.35
  • Is Incyte Stock Undervalued?
    Incyte EV to Free Cash Flow ratio is 11.34
  • What Is Incyte’s Price Earnings Growth Ratio?
    INCY PEG ratio is 0.14
  • Is Incyte Trading At A Premium To Earnings?
    Incyte EV to EBIT ratio is 8.79

Is It Risky To Buy Incyte?

  • How Much Debt Does Incyte Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Incyte Have?
    Cash and short term investments quarterly total is $3.9B
  • What Is Incyte’s Book Value Per Share?
    Book value per share is 24.02

Is Incyte Cash Flow Positive?

  • What Is INCY Cash Flow From Operations?
    Cash flow from operations (TTM) is $820.9M
  • What Is Incyte’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$36.5M
  • What Is Incyte’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$252.2M

Incyte Return On Invested Capital

  • Is Management Doing A Good Job?
    INCY return on invested capital is 15.08%
  • What Is Incyte Return On Assets?
    ROA measures how assets are converting to revenues and is 11.54%
  • What Is INCY Return On Equity?
    ROE is a measure of profitability and is 15.08%

Incyte Earnings Date & Stock Price

  • What Is Incyte's Stock Price Today?
    A single share of INCY can be purchased today for 57.10
  • What Is Incyte’s Stock Symbol?
    Incyte trades on the nasdaq under the ticker symbol: INCY
  • When Is Incyte’s Next Earnings Date?
    The next quarterly earnings date for Incyte is scheduled on August 1, 2024
  • When Is INCY's next ex-dividend date?
    Incyte's next ex-dividend date is May 7, 2020
  • How To Buy Incyte Stock?
    You can buy Incyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Incyte Competitors

  • Who Are Incyte's Competitors?
    Below is a list of companies who compete with Incyte or are related in some way:
    • Bristol-Myers Squibb Co (BMY)
    • Illumina Inc (ILMN)
    • Pfizer Inc (PFE)
    • Syndax Pharmaceuticals Inc (SNDX)
    • Walgreens Boots Alliance Inc (WBA)

Incyte Dividend Yield

Data Unavailable

Incyte Analyst Estimates

YoY Growth Past Surprise
EPS: 650% -23.09%
Revenue: 8.93% -4.73%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 12
Sell Recommendations: 0
Price Target: 73.35
Upside from Last Price: 28.46%

Major Shareholders

  • How many INCY shares are owned by institutional investors?
    323M INCY shares are owned by institutional investors
  • How many INCY shares are owned by insiders?
    3.9M INCY shares are owned by insiders